Morgan Stanley outlines 6 Chinese medical device makers to watch ahead of Q1 earnings

Morgan Stanley has identified six prominent Chinese medical device manufacturers to monitor in anticipation of their first-quarter earnings reports. The firm emphasized sequential recovery, international expansion, and product innovation as crucial growth factors, acknowledging challenges such as U.S.-China tensions, domestic economic slowdown, and potential supply chain disruptions from the Middle East conflict. Detailed outlooks are provided for companies like Mindray Bio-Medical, Shanghai United Imaging Healthcare Co, and APT Medical Inc, focusing on sales growth, net profit, and specific operational considerations.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin